Transcriptomic Analysis Reveals the Protection of Astragaloside IV against Diabetic Nephropathy by Modulating Inflammation

BACKGROUND: Diabetic nephropathy (DN) is one of the leading causes of end-stage kidney disease. Recently, there is no specific drug available to block the kidney damage. Astragaloside IV (AS-IV) is a major active component of Astragalus membranaceus (Fisch) Bge and has been demonstrated to benefit t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yudi, Tao, Chunhe, Xuan, Chen, Jiang, Junyan, Cao, Wenfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443226/
https://www.ncbi.nlm.nih.gov/pubmed/32855769
http://dx.doi.org/10.1155/2020/9542165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443226/
https://www.ncbi.nlm.nih.gov/pubmed/32855769
http://dx.doi.org/10.1155/2020/9542165

Ejemplares similares